Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2Prostatic Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colonic Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 1258Specimen Handling 864Carboplatin 824Magnetic Resonance Spectroscopy 806Cyclophosphamide 798Cisplatin 719Nivolumab 660Paclitaxel 635Gemcitabine 570Radiotherapy 570Biopsy 526Bevacizumab 467Dexamethasone 441fludarabine 403Docetaxel 375venetoclax 369Oxaliplatin 363Capecitabine 355Fluorouracil 354atezolizumab 337Rituximab 333durvalumab 332Doxorubicin 316Pemetrexed 306Radiosurgery 304Drug Therapy 300Ipilimumab 296Standard of Care 288Etoposide 283Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Gene Expression Profiling × 1 year × Clear all
NCT00628368 2026-02-10

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
160 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00977457 2025-08-19

Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery

City of Hope Medical Center

Phase 1 Active not recruiting
1,045 enrolled
Genitourinary

Prostatic Neoplasms

NCT00812669 2025-07-08

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Cancer Trials Ireland

Phase 2 Completed
52 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00873275 2025-06-22

Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

City of Hope Medical Center

Phase 1 Completed
11 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡